News for 'maharashtra food and drug administration'

FDA probe to tarnish our reputation: Subhiksha

FDA probe to tarnish our reputation: Subhiksha

Rediff.com8 Aug 2008

Retail chain Subhiksha feels it is being unfairly targeted by the Food and Drugs Administration (FDA) of Maharashtra in initiating enquiries and hygiene checks on grounds that it is selling repackaged goods. The company would present its case in a hearing scheduled on August 8.

'Ham-handed' action against Snapdeal to hurt business: Pilot

'Ham-handed' action against Snapdeal to hurt business: Pilot

Rediff.com3 May 2015

He said action was akin to holding highway builders responsible for lane violations

Worms found in chocolate packet

Worms found in chocolate packet

Rediff.com3 Oct 2003

Ants in mineral water; Mumbai plant shut

Ants in mineral water; Mumbai plant shut

Rediff.com12 Sep 2003

The presence of ants was detected at Alibag in Maharashtra and subsequently a complaint was lodged with the Food and Drug Administration authorities.

J&J licence to make cosmetics at Mulund plant cancelled

J&J licence to make cosmetics at Mulund plant cancelled

Rediff.com25 Jun 2013

The company has been held responsible for the violation of the Drugs and Cosmetic Act, 1940 and the rules framed in 1945.

Hair oil cos asked to label contents

Hair oil cos asked to label contents

Rediff.com11 Jun 2005

Hetero's generic version of remdesivir to be sold @ Rs 5,400/vial

Hetero's generic version of remdesivir to be sold @ Rs 5,400/vial

Rediff.com24 Jun 2020

The company is set to deliver the first set of 20,000 vials in two equal lots of 10,000 each, one of which will be immediately supplied to Hyderabad, Delhi, Gujarat, Tamil Nadu, Mumbai and other parts of Maharashtra, Hetero Healthcare said in a statement.

Maggi ban: Regulator overreach, says Nestle counsel

Maggi ban: Regulator overreach, says Nestle counsel

Rediff.com21 Jul 2015

Nestle India has been arguing that ban order was arbitrary.

Why India's pharma cos prefer Gujarat over tax havens

Why India's pharma cos prefer Gujarat over tax havens

Rediff.com23 Sep 2017

Gujarat has around 3,000 licensees for allopathic drug manufacturing, apart from around seven homeopathic licensees, 500 ayuvedic and 600-700 cosmetics licensees

Safety concerns over Maggi noodles back to haunt Nestle

Safety concerns over Maggi noodles back to haunt Nestle

Rediff.com30 Nov 2017

This time food regulators found excess presence of ash content in Maggi

Maha portfolios: Sena gets home, NCP finance, Cong revenue

Maha portfolios: Sena gets home, NCP finance, Cong revenue

Rediff.com13 Dec 2019

Portfolios were distributed 2 weeks after the MVA govt was sworn-in. Shiv Sena's Eknath Shinde will be home minister while NCP's Jayant Patil will be finance minister.

AFI chief warns athletes not to take banned drugs by taking advantage of COVID-19 pandemic

AFI chief warns athletes not to take banned drugs by taking advantage of COVID-19 pandemic

Rediff.com31 Oct 2020

AFI President Adille Sumariwalla raised the possibility of more athletes outside the national camp taking to banned drugs and laid a lot of blame on the district and state level coaches.

Now, Goa bans sale of Maggi; 11th state to ban noodle brand

Now, Goa bans sale of Maggi; 11th state to ban noodle brand

Rediff.com7 Jun 2015

Goa on Sunday joined several other states in banning the sale of Nestle's instant noodle brand 'Maggi' which is at the centre of a raging nationwide row over food safety concerns.

Maggi to lose $200 mn in brand value

Maggi to lose $200 mn in brand value

Rediff.com18 Jun 2015

Asset valuation consultancy sees brand value slip to $2.2 billion.

China may commit $6.5 billion for industrial parks in India

China may commit $6.5 billion for industrial parks in India

Rediff.com17 Sep 2014

China is expected to commit investments worth $6.5 billion to set up industrial parks in India and sign purchase agreements of over $3 billion with domestic companies during the visit of Chinese President Xi Jinping starting on Wednesday.

Maggi in a soup: Brands that fought back controversies and regained trust

Maggi in a soup: Brands that fought back controversies and regained trust

Rediff.com6 Jun 2015

Instant noodle from Nestle is not the first food brand in India to have faced a tough time though

Experts unsure of Maha move to challenge Maggi in Supreme Court

Experts unsure of Maha move to challenge Maggi in Supreme Court

Rediff.com16 Nov 2015

Maggi re-entered the market on November 9.

Johnson & Johnson allowed to manufacture and sell baby powder

Johnson & Johnson allowed to manufacture and sell baby powder

Rediff.com11 Jan 2023

The Bombay high court on Wednesday permitted Johnson & Johnson to manufacture, sell and distribute its baby powder and quashed three orders of the Maharashtra government revoking the company's license and asking it to stop the product manufacture and sale, terming them as "stringent, unreasonable and unfair". A division bench of Justices Gautam Patel and S G Dige also came down heavily on the state Food and Drug Administration (FDA) for its delay in carrying out tests on a sample of the company's baby powder seized in December 2018. The bench noted that while maintaining standards of quality and safety are of utmost importance for cosmetic products, at the same time it does not seem reasonable to shut down the whole manufacturing process when there is a slight deviation in one of the products.

Major rejig of portfolios after Fadnavis' cabinet expansion

Major rejig of portfolios after Fadnavis' cabinet expansion

Rediff.com10 Jul 2016

Maharashtra Chief Minister Devendra Fadnavis on Saturday allocated portfolios to newly sworn-in ministers and reshuffled certain portfolios.

Fadnavis allocates portfolios; BJP retains key depts

Fadnavis allocates portfolios; BJP retains key depts

Rediff.com6 Dec 2014

Maharashtra Chief Minister Devendra Fadnavis on Saturday allocated portfolios to the twenty-member council of ministers, including 10 of the Shiv Sena, who were inducted into his expanded cabinet.

Wockhardt's Shendra unit set for key US test

Wockhardt's Shendra unit set for key US test

Rediff.com7 Jan 2014

If the company manages to get a go-ahead from the regulator for this plant, it might result in resumption of supplies of several of their products, barred from the US last year.

Maha portfolios: Ajit Pawar gets finance; Aaditya tourism

Maha portfolios: Ajit Pawar gets finance; Aaditya tourism

Rediff.com5 Jan 2020

With this allocation of portfolios, the Sharad Pawar-led NCP has got most of the 'plum' ministries.

UK health regulator withdraws nod for another Wockhardt unit

UK health regulator withdraws nod for another Wockhardt unit

Rediff.com22 Oct 2013

The company has received a communication from the Medicines and Healthcare Products Regulatory Agency, United Kingdom, whereby the agency has decided to withdraw the previously issued GMP Certificate to the company's manufacturing facility situated at Kadaiya, Nani Daman, Wockhardt said in a filing to the Bombay Stock Exchange.

Pharma sector in alarm over govt's cure

Pharma sector in alarm over govt's cure

Rediff.com28 Oct 2017

The government plans to rationalise trade margins for many other medical devices, besides stents and knee implants.

As Maggi goes off menu, Nestle gears up for damage control

As Maggi goes off menu, Nestle gears up for damage control

Rediff.com28 May 2015

The central government has said it will look into the matter.

Fadnavis gets home, finance; BJP bags key portfolios in Maha cabinet

Fadnavis gets home, finance; BJP bags key portfolios in Maha cabinet

Rediff.com14 Aug 2022

Five days after the induction of 18 ministers into his cabinet, Maharashtra Chief Minister Eknath Shinde on Sunday allocated portfolios, keeping Urban Development and 11 other ministries with himself, while giving the crucial Home Department to Deputy CM Devendra Fadnavis.

Wockhardt medicines banned in Europe

Wockhardt medicines banned in Europe

Rediff.com11 Jul 2013

Its Waluj manufacturing facility in Maharashtra failed to meet the good manufacturing norms prescribed by the UK drug regulator.

The big plan: Nestle gearing up for Maggi's comeback

The big plan: Nestle gearing up for Maggi's comeback

Rediff.com19 Jun 2015

Nestle is sure to go for a relaunch of the noodles soon enough with an advertising blitz,

3 Indian pharma firms named in US Congress price probe

3 Indian pharma firms named in US Congress price probe

Rediff.com9 Oct 2014

Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months

When it comes to pharma, Made in Gujarat is a success story

When it comes to pharma, Made in Gujarat is a success story

Rediff.com2 Jun 2016

The percentage of non-standard quality drugs in the state has been in the range of 2-2.5% as compared to an all-India average of 5-6%

Amul raids open a can of worms

Amul raids open a can of worms

Rediff.com29 Jan 2005

Profit booking, global cues subdue markets; Nifty holds 8,300

Profit booking, global cues subdue markets; Nifty holds 8,300

Rediff.com8 Jul 2016

Midcap stocks continued to remain on buyers' radar with BSE Midcap index up 0.1%.

'Khalistanis are a microscopic minority in Punjab'

'Khalistanis are a microscopic minority in Punjab'

Rediff.com4 Apr 2023

'The Khalistanis get bulk of the money from abroad.' 'Where did Amritpal's Mercedes come from, which costs well over Rs 60 lakhs?' 'Where does his fleet of vehicles come from?' 'Local Punjabis can certainly not contribute this kind of money.'

The A-W Of Desi Guests At the White House Dinner

The A-W Of Desi Guests At the White House Dinner

Rediff.com24 Jun 2023

The dinner Jill Biden and her husband US President Joe Biden hosted for Indian prime minister Narendra Modi, June 22, at the White House brought together, Indians and Americans from so many firmaments.

Markets pause after 3-day bull run

Markets pause after 3-day bull run

Rediff.com4 Mar 2016

Asian shares ended higher after a string of positive US economic data.

Bulls keep winning streak intact; Sensex ends 134 points higher

Bulls keep winning streak intact; Sensex ends 134 points higher

Rediff.com4 Jul 2016

Gains were led by Tata Motors amid robust sales in June along with select financials.

'The government's priorities are all wrong'

'The government's priorities are all wrong'

Rediff.com14 Apr 2020

'The prime minister did not think that COVID-19 was a serious challenge as late as March 20.'

ICMR asks states not to use rapid test kits for 2 days

ICMR asks states not to use rapid test kits for 2 days

Rediff.com21 Apr 2020

"We have received complaint from a state yesterday and so far discussed with three states. Too much variations have been reported in results of rapid test kits and RT-PCR kits. We advise states not to use them for the next two days," ICMR's Dr Raman R Gangakhedkar said.

How Amul is quelling the 'non-veg' rumours

How Amul is quelling the 'non-veg' rumours

Rediff.com21 Sep 2018

This is not the first time Gujarat Cooperative Milk Marketing Federation that owns brand Amul has chosen an unconventional method to protect its brand.

If there are 70,000 cases in May...Mumbai is ready

If there are 70,000 cases in May...Mumbai is ready

Rediff.com2 May 2020

'Our preparation is based on ICMR projections, whatever preparations we have to make.' 'If they project around 70,000 is the maximum number of hospital cases by mid-May or May 30, we are preparing accordingly -- how many people will need hospitalisation.'